4 completed, 1 terminated. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Terminated 1 |
Follow ipragliflozin: new trials by email Literature Review of ipragliflozin trials Research Report on ipragliflozin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Diabetes Mellitus, Type 2 (4) · Diabetes Mellitus (1) · Insulin Resistance (1) · Non-alcoholic Fatty Liver Disease (1)
Astellas Pharma Inc (3) · Astellas Pharma Korea, Inc. (1) · Yonsei University (1)
Japan (3) · South Korea (2)